Trial intelligence / Profile preview

Periochip in Peri-implantitis

NCT01079663Phase 2Completed

Sponsor
Dexcel Pharma
Start
Mar 2010
Primary completion
Oct 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of chlorhexidine in peri-implantitis, sponsored by Dexcel Pharma. Started Mar 2010; status: completed.

02

Drugs

chlorhexidine
03

Conditions

peri-implantitis

Beyond the preview

Go deeper on NCT01079663.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01079663.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call